American College of Cardiology

The American College of Cardiology (ACC) is a prominent professional medical society dedicated to transforming cardiovascular care and improving heart health globally. The ACC engages in various initiatives, including the ACC Innovation Program, which collaborates with industry and academic institutions to advance cardiovascular care through digital transformation. This program supports the development of technologies that enhance patient outcomes and optimize cardiovascular care.

In addition to its innovation efforts, the ACC Foundation invests in a diverse portfolio of companies, such as Myia, cliexa, AngelMD, Abridge, Heart Hero, Heartbeat Health, Carta, Butterfly, Cleerly, Dispatch, and Commure. These investments aim to support advancements in healthcare technology and services, aligning with the ACC's mission to improve cardiovascular care. It's important to note that these investments do not constitute a guarantee or endorsement by the ACC Foundation or the ACC of a specific product, service, or therapy offered by these companies.

The ACC's strategic direction focuses on increasing relevance as the cardiovascular professional home, advancing health equity, empowering future leaders, and improving global heart health. Through these initiatives, the ACC continues to lead in the transformation of cardiovascular care, ensuring that science, knowledge, and innovation optimize patient care and outcomes worldwide.